APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharma Continuous Granulation

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pharma Continuous Granulation Industry Growth and Trends Forecast to 2032

Report ID 173839150129 December 2025103 pages

Choose your research edition.

Industry ResearchPharma Continuous Granulation Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma Continuous Granulation Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pharma Continuous Granulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma Continuous Granulation Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma Continuous Granulation Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Pharma Continuous Granulation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pharma Continuous Granulation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pharma Continuous Granulation is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharma Continuous Granulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharma Continuous Granulation include LB Bohle, GEA, LCI, Chansemt, Thermo Fisher Scientific, Syntegon, Senieer, LÖDIGE and Glatt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pharma Continuous Granulation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pharma Continuous Granulation market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharma Continuous Granulation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharma Continuous Granulation.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pharma Continuous Granulation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pharma Continuous Granulation Market by Company

LB Bohle

GEA

LCI

Chansemt

Thermo Fisher Scientific

Syntegon

Senieer

LÖDIGE

Glatt

Gericke

Pharma Continuous Granulation Segment by Type

Dry Method

Wet Method

Pharma Continuous Granulation Segment by Application

Tablets

Capsules

Others

Pharma Continuous Granulation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Continuous Granulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma Continuous Granulation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Continuous Granulation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharma Continuous Granulation manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pharma Continuous Granulation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Dry Method Table 2. Major Company of Wet Method Table 3. Global Pharma Continuous Granulation Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Pharma Continuous Granulation Sales by Type (2021-2026) & (K Units) Table 5. Global Pharma Continuous Granulation Sales Market Share in Volume by Type (2021-2026) Table 6. Global Pharma Continuous Granulation Sales by Type (2021-2026) & (US$ Million) Table 7. Global Pharma Continuous Granulation Sales Market Share in Value by Type (2021-2026) Table 8. Global Pharma Continuous Granulation Price by Type (2021-2026) & (US$/Unit) Table 9. Global Pharma Continuous Granulation Sales by Type (2027-2032) & (K Units) Table 10. Global Pharma Continuous Granulation Sales Market Share in Volume by Type (2027-2032) Table 11. Global Pharma Continuous Granulation Sales by Type (2027-2032) & (US$ Million) Table 12. Global Pharma Continuous Granulation Sales Market Share in Value by Type (2027-2032) Table 13. Global Pharma Continuous Granulation Price by Type (2027-2032) & (US$/Unit) Table 14. North America Pharma Continuous Granulation Sales by Type (2021-2026) & (K Units) Table 15. North America Pharma Continuous Granulation Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Pharma Continuous Granulation Sales by Type (2021-2026) & (K Units) Table 17. Europe Pharma Continuous Granulation Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Pharma Continuous Granulation Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Pharma Continuous Granulation Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Pharma Continuous Granulation Sales by Type (2021-2026) & (K Units) Table 21. Latin America Pharma Continuous Granulation Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Pharma Continuous Granulation Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Pharma Continuous Granulation Sales by Type (2021-2026) & (US$ Million) Table 24. Pharma Continuous Granulation Industry Trends Table 25. Pharma Continuous Granulation Industry Drivers Table 26. Pharma Continuous Granulation Industry Opportunities and Challenges Table 27. Pharma Continuous Granulation Industry Restraints Table 28. Global Pharma Continuous Granulation Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Pharma Continuous Granulation Revenue Market Share by Company (2021-2026) Table 30. Global Pharma Continuous Granulation Sales by Company (2021-2026) & (K Units) Table 31. Global Pharma Continuous Granulation Sales Share by Company (2021-2026) Table 32. Global Pharma Continuous Granulation Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Pharma Continuous Granulation Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pharma Continuous Granulation Major Company Production Sites and Headquarters Table 35. Global Pharma Continuous Granulation Company, Product Type & Application Table 36. Global Pharma Continuous Granulation Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Pharma Continuous Granulation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pharma Continuous Granulation Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Pharma Continuous Granulation Sales by Region (2021-2026) & (K Units) Table 41. Global Pharma Continuous Granulation Sales Market Share in Volume by Region (2021-2026) Table 42. Global Pharma Continuous Granulation Sales by Region (2021-2026) & (US$ Million) Table 43. Global Pharma Continuous Granulation Sales Market Share in Value by Region (2021-2026) Table 44. Global Pharma Continuous Granulation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Pharma Continuous Granulation Sales by Region (2027-2032) & (K Units) Table 46. Global Pharma Continuous Granulation Sales Market Share in Volume by Region (2027-2032) Table 47. Global Pharma Continuous Granulation Sales by Region (2027-2032) & (US$ Million) Table 48. Global Pharma Continuous Granulation Sales Market Share in Value by Region (2027-2032) Table 49. Global Pharma Continuous Granulation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Pharma Continuous Granulation Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Pharma Continuous Granulation Sales by Application (2021-2026) & (K Units) Table 52. Global Pharma Continuous Granulation Sales Market Share in Volume by Application (2021-2026) Table 53. Global Pharma Continuous Granulation Sales by Application (2021-2026) & (US$ Million) Table 54. Global Pharma Continuous Granulation Sales Market Share in Value by Application (2021-2026) Table 55. Global Pharma Continuous Granulation Price by Application (2021-2026) & (US$/Unit) Table 56. Global Pharma Continuous Granulation Sales by Application (2027-2032) & (K Units) Table 57. Global Pharma Continuous Granulation Sales Market Share in Volume by Application (2027-2032) Table 58. Global Pharma Continuous Granulation Sales by Application (2027-2032) & (US$ Million) Table 59. Global Pharma Continuous Granulation Sales Market Share in Value by Application (2027-2032) Table 60. Global Pharma Continuous Granulation Price by Application (2027-2032) & (US$/Unit) Table 61. North America Pharma Continuous Granulation Sales by Application (2021-2026) & (K Units) Table 62. North America Pharma Continuous Granulation Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Pharma Continuous Granulation Sales by Application (2021-2026) & (K Units) Table 64. Europe Pharma Continuous Granulation Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Pharma Continuous Granulation Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Pharma Continuous Granulation Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Pharma Continuous Granulation Sales by Application (2021-2026) & (K Units) Table 68. Latin America Pharma Continuous Granulation Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Pharma Continuous Granulation Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Pharma Continuous Granulation Sales by Application (2021-2026) & (US$ Million) Table 71. LB Bohle Company Information Table 72. LB Bohle Business Overview Table 73. LB Bohle Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. LB Bohle Pharma Continuous Granulation Product Portfolio Table 75. LB Bohle Recent Development Table 76. GEA Company Information Table 77. GEA Business Overview Table 78. GEA Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. GEA Pharma Continuous Granulation Product Portfolio Table 80. GEA Recent Development Table 81. LCI Company Information Table 82. LCI Business Overview Table 83. LCI Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. LCI Pharma Continuous Granulation Product Portfolio Table 85. LCI Recent Development Table 86. Chansemt Company Information Table 87. Chansemt Business Overview Table 88. Chansemt Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Chansemt Pharma Continuous Granulation Product Portfolio Table 90. Chansemt Recent Development Table 91. Thermo Fisher Scientific Company Information Table 92. Thermo Fisher Scientific Business Overview Table 93. Thermo Fisher Scientific Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Thermo Fisher Scientific Pharma Continuous Granulation Product Portfolio Table 95. Thermo Fisher Scientific Recent Development Table 96. Syntegon Company Information Table 97. Syntegon Business Overview Table 98. Syntegon Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Syntegon Pharma Continuous Granulation Product Portfolio Table 100. Syntegon Recent Development Table 101. Senieer Company Information Table 102. Senieer Business Overview Table 103. Senieer Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Senieer Pharma Continuous Granulation Product Portfolio Table 105. Senieer Recent Development Table 106. LÖDIGE Company Information Table 107. LÖDIGE Business Overview Table 108. LÖDIGE Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. LÖDIGE Pharma Continuous Granulation Product Portfolio Table 110. LÖDIGE Recent Development Table 111. Glatt Company Information Table 112. Glatt Business Overview Table 113. Glatt Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Glatt Pharma Continuous Granulation Product Portfolio Table 115. Glatt Recent Development Table 116. Gericke Company Information Table 117. Gericke Business Overview Table 118. Gericke Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Gericke Pharma Continuous Granulation Product Portfolio Table 120. Gericke Recent Development Table 121. North America Pharma Continuous Granulation Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Pharma Continuous Granulation Sales by Country (2021-2026) & (K Units) Table 123. North America Pharma Continuous Granulation Sales Market Share by Country (2021-2026) Table 124. North America Pharma Continuous Granulation Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Pharma Continuous Granulation Sales Market Share Forecast by Country (2027-2032) Table 126. North America Pharma Continuous Granulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Pharma Continuous Granulation Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Pharma Continuous Granulation Market Share by Country (2021-2026) Table 129. North America Pharma Continuous Granulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Pharma Continuous Granulation Market Share Forecast by Country (2027-2032) Table 131. Europe Pharma Continuous Granulation Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Pharma Continuous Granulation Sales by Country (2021-2026) & (K Units) Table 133. Europe Pharma Continuous Granulation Sales Market Share by Country (2021-2026) Table 134. Europe Pharma Continuous Granulation Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Pharma Continuous Granulation Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Pharma Continuous Granulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Pharma Continuous Granulation Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Pharma Continuous Granulation Market Share by Country (2021-2026) Table 139. Europe Pharma Continuous Granulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Pharma Continuous Granulation Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Pharma Continuous Granulation Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Pharma Continuous Granulation Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Pharma Continuous Granulation Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Pharma Continuous Granulation Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Pharma Continuous Granulation Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Pharma Continuous Granulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Pharma Continuous Granulation Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Pharma Continuous Granulation Market Share by Country (2021-2026) Table 149. Asia-Pacific Pharma Continuous Granulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Pharma Continuous Granulation Market Share Forecast by Country (2027-2032) Table 151. Latin America Pharma Continuous Granulation Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Pharma Continuous Granulation Sales by Country (2021-2026) & (K Units) Table 153. Latin America Pharma Continuous Granulation Sales Market Share by Country (2021-2026) Table 154. Latin America Pharma Continuous Granulation Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Pharma Continuous Granulation Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Pharma Continuous Granulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Pharma Continuous Granulation Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Pharma Continuous Granulation Market Share by Country (2021-2026) Table 159. Latin America Pharma Continuous Granulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Pharma Continuous Granulation Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Pharma Continuous Granulation Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Pharma Continuous Granulation Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Pharma Continuous Granulation Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Pharma Continuous Granulation Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Pharma Continuous Granulation Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Pharma Continuous Granulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Pharma Continuous Granulation Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Pharma Continuous Granulation Market Share by Country (2021-2026) Table 169. Middle East and Africa Pharma Continuous Granulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Pharma Continuous Granulation Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Pharma Continuous Granulation Distributors List Table 174. Pharma Continuous Granulation Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Pharma Continuous Granulation Image Figure 2. Global Pharma Continuous Granulation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharma Continuous Granulation Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharma Continuous Granulation Sales (2021-2032) & (K Units) Figure 5. Dry Method Image Figure 6. Global Dry Method Sales YoY Growth (2021-2032) & (K Units) Figure 7. Wet Method Image Figure 8. Global Wet Method Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Pharma Continuous Granulation Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Pharma Continuous Granulation Market Share by Type 2025 VS 2032 Figure 11. North America Pharma Continuous Granulation Sales Market Share in Volume by Type in 2025 Figure 12. North America Pharma Continuous Granulation Sales Market Share in Value by Type in 2025 Figure 13. Europe Pharma Continuous Granulation Sales Market Share in Volume by Type in 2025 Figure 14. Europe Pharma Continuous Granulation Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Pharma Continuous Granulation Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Pharma Continuous Granulation Sales Market Share in Value by Type in 2025 Figure 17. Latin America Pharma Continuous Granulation Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Pharma Continuous Granulation Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Pharma Continuous Granulation Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Pharma Continuous Granulation Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Pharma Continuous Granulation Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Tablets Image Figure 24. Global Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 25. Capsules Image Figure 26. Global Capsules Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Pharma Continuous Granulation Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Pharma Continuous Granulation Market Share by Application 2025 VS 2032 Figure 31. North America Pharma Continuous Granulation Sales Market Share in Volume by Application in 2025 Figure 32. North America Pharma Continuous Granulation Sales Market Share in Value by Application in 2025 Figure 33. Europe Pharma Continuous Granulation Sales Market Share in Volume by Application in 2025 Figure 34. Europe Pharma Continuous Granulation Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Pharma Continuous Granulation Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Pharma Continuous Granulation Sales Market Share in Value by Application in 2025 Figure 37. Latin America Pharma Continuous Granulation Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Pharma Continuous Granulation Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Pharma Continuous Granulation Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Pharma Continuous Granulation Sales Market Share in Value by Application in 2025 Figure 41. North America Pharma Continuous Granulation Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Pharma Continuous Granulation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Pharma Continuous Granulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Pharma Continuous Granulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Pharma Continuous Granulation Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Pharma Continuous Granulation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pharma Continuous Granulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Pharma Continuous Granulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Pharma Continuous Granulation Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Pharma Continuous Granulation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pharma Continuous Granulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Pharma Continuous Granulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pharma Continuous Granulation Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Pharma Continuous Granulation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pharma Continuous Granulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Pharma Continuous Granulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Pharma Continuous Granulation Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Pharma Continuous Granulation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pharma Continuous Granulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Pharma Continuous Granulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Pharma Continuous Granulation Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Pharma Continuous Granulation Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Dry Method
  • Wet Method
Applications
  • Tablets
  • Capsules
  • Others
Companies covered
  • LB Bohle
  • GEA
  • LCI
  • Chansemt
  • Thermo Fisher Scientific
  • Syntegon
  • Senieer
  • LÖDIGE
  • Glatt
  • Gericke

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharma Continuous Granulation Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pharma Continuous Granulation Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pharma Continuous Granulation Market by Type
  6. 1.3.1 Dry Method
  7. 1.3.2 Wet Method
  8. 1.4 Global Pharma Continuous Granulation Market Size by Type
  9. 1.4.1 Global Pharma Continuous Granulation Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Pharma Continuous Granulation Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Pharma Continuous Granulation Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Pharma Continuous Granulation Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Pharma Continuous Granulation Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Pharma Continuous Granulation Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Pharma Continuous Granulation Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Pharma Continuous Granulation Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pharma Continuous Granulation Industry Trends
  2. 2.2 Pharma Continuous Granulation Industry Drivers
  3. 2.3 Pharma Continuous Granulation Industry Opportunities and Challenges
  4. 2.4 Pharma Continuous Granulation Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pharma Continuous Granulation Revenue (2021-2026)
  2. 3.2 Global Top Players by Pharma Continuous Granulation Sales (2021-2026)
  3. 3.3 Global Top Players by Pharma Continuous Granulation Price (2021-2026)
  4. 3.4 Global Pharma Continuous Granulation Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharma Continuous Granulation Major Company Production Sites & Headquarters
  6. 3.6 Global Pharma Continuous Granulation Company, Product Type & Application
  7. 3.7 Global Pharma Continuous Granulation Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharma Continuous Granulation Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharma Continuous Granulation Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pharma Continuous Granulation Tier 1, Tier 2, and Tier 3
4 Pharma Continuous Granulation Regional Status and Outlook
  1. 4.1 Global Pharma Continuous Granulation Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pharma Continuous Granulation Historic Market Size by Region
  3. 4.2.1 Global Pharma Continuous Granulation Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pharma Continuous Granulation Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pharma Continuous Granulation Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pharma Continuous Granulation Forecasted Market Size by Region
  7. 4.3.1 Global Pharma Continuous Granulation Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pharma Continuous Granulation Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pharma Continuous Granulation Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pharma Continuous Granulation by Application
  1. 5.1 Pharma Continuous Granulation Market by Application
  2. 5.1.1 Tablets
  3. 5.1.2 Capsules
  4. 5.1.3 Others
  5. 5.2 Global Pharma Continuous Granulation Market Size by Application
  6. 5.2.1 Global Pharma Continuous Granulation Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pharma Continuous Granulation Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pharma Continuous Granulation Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pharma Continuous Granulation Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pharma Continuous Granulation Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pharma Continuous Granulation Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pharma Continuous Granulation Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pharma Continuous Granulation Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 LB Bohle
  2. 6.1.1 LB Bohle Company Information
  3. 6.1.2 LB Bohle Business Overview
  4. 6.1.3 LB Bohle Pharma Continuous Granulation Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 LB Bohle Pharma Continuous Granulation Product Portfolio
  6. 6.1.5 LB Bohle Recent Developments
  7. 6.2 GEA
  8. 6.2.1 GEA Company Information
  9. 6.2.2 GEA Business Overview
  10. 6.2.3 GEA Pharma Continuous Granulation Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GEA Pharma Continuous Granulation Product Portfolio
  12. 6.2.5 GEA Recent Developments
  13. 6.3 LCI
  14. 6.3.1 LCI Company Information
  15. 6.3.2 LCI Business Overview
  16. 6.3.3 LCI Pharma Continuous Granulation Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 LCI Pharma Continuous Granulation Product Portfolio
  18. 6.3.5 LCI Recent Developments
  19. 6.4 Chansemt
  20. 6.4.1 Chansemt Company Information
  21. 6.4.2 Chansemt Business Overview
  22. 6.4.3 Chansemt Pharma Continuous Granulation Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Chansemt Pharma Continuous Granulation Product Portfolio
  24. 6.4.5 Chansemt Recent Developments
  25. 6.5 Thermo Fisher Scientific
  26. 6.5.1 Thermo Fisher Scientific Company Information
  27. 6.5.2 Thermo Fisher Scientific Business Overview
  28. 6.5.3 Thermo Fisher Scientific Pharma Continuous Granulation Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Thermo Fisher Scientific Pharma Continuous Granulation Product Portfolio
  30. 6.5.5 Thermo Fisher Scientific Recent Developments
  31. 6.6 Syntegon
  32. 6.6.1 Syntegon Company Information
  33. 6.6.2 Syntegon Business Overview
  34. 6.6.3 Syntegon Pharma Continuous Granulation Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Syntegon Pharma Continuous Granulation Product Portfolio
  36. 6.6.5 Syntegon Recent Developments
  37. 6.7 Senieer
  38. 6.7.1 Senieer Company Information
  39. 6.7.2 Senieer Business Overview
  40. 6.7.3 Senieer Pharma Continuous Granulation Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Senieer Pharma Continuous Granulation Product Portfolio
  42. 6.7.5 Senieer Recent Developments
  43. 6.8 LÖDIGE
  44. 6.8.1 LÖDIGE Company Information
  45. 6.8.2 LÖDIGE Business Overview
  46. 6.8.3 LÖDIGE Pharma Continuous Granulation Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 LÖDIGE Pharma Continuous Granulation Product Portfolio
  48. 6.8.5 LÖDIGE Recent Developments
  49. 6.9 Glatt
  50. 6.9.1 Glatt Company Information
  51. 6.9.2 Glatt Business Overview
  52. 6.9.3 Glatt Pharma Continuous Granulation Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Glatt Pharma Continuous Granulation Product Portfolio
  54. 6.9.5 Glatt Recent Developments
  55. 6.10 Gericke
  56. 6.10.1 Gericke Company Information
  57. 6.10.2 Gericke Business Overview
  58. 6.10.3 Gericke Pharma Continuous Granulation Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Gericke Pharma Continuous Granulation Product Portfolio
  60. 6.10.5 Gericke Recent Developments
7 North America by Country
  1. 7.1 North America Pharma Continuous Granulation Sales by Country
  2. 7.1.1 North America Pharma Continuous Granulation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pharma Continuous Granulation Sales by Country (2021-2026)
  4. 7.1.3 North America Pharma Continuous Granulation Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pharma Continuous Granulation Market Size by Country
  6. 7.2.1 North America Pharma Continuous Granulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pharma Continuous Granulation Market Size by Country (2021-2026)
  8. 7.2.3 North America Pharma Continuous Granulation Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pharma Continuous Granulation Sales by Country
  2. 8.1.1 Europe Pharma Continuous Granulation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pharma Continuous Granulation Sales by Country (2021-2026)
  4. 8.1.3 Europe Pharma Continuous Granulation Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pharma Continuous Granulation Market Size by Country
  6. 8.2.1 Europe Pharma Continuous Granulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pharma Continuous Granulation Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pharma Continuous Granulation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pharma Continuous Granulation Sales by Country
  2. 9.1.1 Asia-Pacific Pharma Continuous Granulation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pharma Continuous Granulation Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pharma Continuous Granulation Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pharma Continuous Granulation Market Size by Country
  6. 9.2.1 Asia-Pacific Pharma Continuous Granulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pharma Continuous Granulation Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pharma Continuous Granulation Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pharma Continuous Granulation Sales by Country
  2. 10.1.1 South America Pharma Continuous Granulation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pharma Continuous Granulation Sales by Country (2021-2026)
  4. 10.1.3 South America Pharma Continuous Granulation Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pharma Continuous Granulation Market Size by Country
  6. 10.2.1 South America Pharma Continuous Granulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pharma Continuous Granulation Market Size by Country (2021-2026)
  8. 10.2.3 South America Pharma Continuous Granulation Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pharma Continuous Granulation Sales by Country
  2. 11.1.1 Middle East and Africa Pharma Continuous Granulation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pharma Continuous Granulation Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pharma Continuous Granulation Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pharma Continuous Granulation Market Size by Country
  6. 11.2.1 Middle East and Africa Pharma Continuous Granulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pharma Continuous Granulation Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pharma Continuous Granulation Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pharma Continuous Granulation Value Chain Analysis
  2. 12.1.1 Pharma Continuous Granulation Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pharma Continuous Granulation Production Mode & Process
  7. 12.2 Pharma Continuous Granulation Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pharma Continuous Granulation Distributors
  10. 12.2.3 Pharma Continuous Granulation Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst